Estimation of Percentage of Patients With Fibroblast Growth Factor Receptor Alterations Eligible for Off-label Use of Erdafitinib
- Lelia Maria de Almeida Carvalho
- , Sandra de Oliveira Sapori Avelar
- , Alyson Haslam
- , Jennifer Gill
- , Vinay Prasad
Research output: Contribution to journal › Article › peer-review
17
Link opens in a new tab
Scopus
citations